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SUMMARY
Anti-pneumococcal polysaccharide antibody (anti-PPS) levels were measured in
153 serum samples collected from children aged between 2 and 47 months living
in the highlands of Papua New Guinea (PNG). Fifty-seven of the samples were
collected during acute episodes of lower respiratory tract infection (ALRI). Total
IgA and IgG increased steadily with age; however, no association was found
between the levels of these antibodies and the health status of the child. Total IgM
levels showed little relationship to the age of the child but under 12 months of age
levels were somewhat higher on average in children with pneumonia. For most of
eight pneumococcal serotypes tested, specific IgG levels were found to decline
rapidly in the first 6-8 months, reaching a minimum at approximately 12 months
of age. Serotype 3 was exceptional in having very low titres in the youngest
children. A separate analysis of 24 cord sera suggested that antibodies to this
serotype do not usually cross the placenta in PNG. Children with pneumonia
tended to have lower levels of specific IgG than healthy controls of the same age.
Specific anti-PPS IgA levels were found to increase steadily with age, but were not
associated with health status.
INTRODUCTION
Pneumonia is the commonest cause of hospital admission and death in both
children and adults in Papua New Guinea (PNG) [1,2]. The most commonly
isolated bacterial agents are Streptococcus pneumoniae and Haemophilus influenzae,
one or both of which can be isolated from lung aspirates and blood culture of more
than 60% of children with moderate or severe pneumonia [1]. Pneumococcal
vaccines have been shown to reduce pneumonia-associated mortality in the
highlands of Papua New Guinea [3].
Antibody responses of children in developed countries have been well
documented: pneumococcal vaccine, like other capsular polysaccharide vaccines,
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does not stimulate an antibody response in young children as efficiently as it does
in adults [4, 5]. However, antibody responses to pneumococcal polysaccharides,
both natural and vaccine-related, in children living in the highlands of Papua New
Guinea are not well understood. These children face an environment very different
from that encountered in developed nations, and these differences may be
compounded by differences in genetic makeup.
A case-control study of children in the highlands of PNG has shown that those
with moderate or severe pneumonia have lower levels of anti-pneumococcal
polysaccharide IgG than age-matched healthy children [6, 7]. This report relates
to a separate community-based study aimed to determine the ages at which
children naturally acquire anti-pneumococcal polysaccharide antibody (anti-PPS)
and the levels of anti-PPS in children in the Community. We also consider whether
there is any change in these levels when the child has an episode of mild
pneumonia and whether the levels are related to carriage of the corresponding
serotype in the upper respiratory tract.
MATERIALS AND METHODS
Subjects and samples
All subjects in this study were participants in a Community study of respiratory
morbidity in 156 children under 5 years of age in the Asaro Valley, Eastern
Highlands Province. Details of the morbidity surveillance are reported elsewhere
[8]. The definition of pneumonia used and the morbidity rates are reported by
Smith and colleagues [9].
Briefly, after informed consent had been obtained from the mothers, blood
samples and nasal swabs were collected from the children on entry to the study.
Nasal swabs were transported to the bacteriology laboratories of the PNG
Institute of Medical Research in Goroka and cultured using Standard methods to
detect and type S. pneumoniae [8]. Serum samples were aliquotted and stored at
— 50 °C. Further blood samples and nasal swabs were collected at approximately
6-monthly intervals from healthy children, and also whenever the child developed
Symptoms of pneumonia. The duration of the study was 18 months.
Pneumococcal antibody levels were measured in randomly selected samples
from healthy children (i.e. those not currently suffering from pneumonia) in each
age group. Samples from children with pneumonia were tested where available. In
many cases this resulted in the selection of sequential samples from the same child.
Determination of antibody levels
Total IgA, IgG and IgM class antibody levels were measured by electro-
immunoassay. IgA and IgG class antibody titres to eight serotypes of pneumococci
(types 2, 3, 5, 6B, 7F, 14, 19F, and 23F) were measured by ELISA as described
previously [6]. Briefly, 100/^1 pneumococcal polysaccharide antigens diluted in
PBS (phosphate-buffered saline) were incubated in ELISA plates at room
temperature for 15 min. Serum samples, diluted at 1/25 in PBS/Tween+ 10%
fkim milk, were added after five washes in PBS/Tween. After 90 min of incubation
it room temperature, 100 fi\ of alkaline-phosphatase-conjugated goat anti-human
[gG (Tago Inc., Burlingame, CA, USA) diluted 1/2000 in PBS/Tween + 5% skim
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milk powder was added and incubated for a further 90 min at room temperature.
After five washes with PBS/Tween, 100 /A of enzyme substrate (product no. 104-
105, Sigma, St Louis, MO, USA) was added and the optical density was read after
30 min at 405 nm using a Titertek Multiscan II plate reader. Purified capsular
polysaccharide antigens were kindly supplied by Institut Merieux, Lyon, France.
Each ELISA run included a standard serum (pooled serum) of known titre
which allowed the construction of standard curves of optical density against titre
which were used to convert optical density to antibody titres.
Statistical analysis
Since levels of different antibodies in the same child are correlated, the results
of separate statistical analyses for each serotype would not be independent.
We therefore aggregated the data for all serotypes and carried out overall tests
which allowed for this correlation structure and for the differences between
serotypes in the mean levels. This procedure enabled a more powerful statistical
analysis to be carried out, and avoided the need for corrections for multiple testing
which would be associated with a large number of significance tests.
The logarithmically transformed antibody titres were thus modelled using a
multivariate normal regression model fitted by maximum likelihood using the
program FISHER [10, 11]. Within this model, age effects were allowed for by
polynomial regression. The correlations between repeated measurements of the
same antibody in the same child, and between levels of different antibodies in
the same sample were allowed for by modelling the variance—covariance of the
residuals, using the approach suggested by Diggle [12] for analysing repeated
measures data.
Significance testing was carried out by including extra terms in the model for (i)
whether specific antibody levels are different in pneumonia cases, and (ii) whether
specific antibody levels are different when the same serotype of S. pneumoniae is
carried in the nose. Statistical significance was then assessed by likelihood ratio
tests. Two-tailed tests were used.
A simplified model, which did not include terms which depended on the
serotype, was used to analyse total antibody levels.
RESULTS
Specimens from a total of 71 children were analysed. Ages of the children when
the specimens were collected varied from 26 to 46-6 months, with a median age of
20-4 months. The distribution of the number of specimens per child is shown in
Table 1. Of the total 153 specimens, 57 (37-3%) were collected when the children
had an episode of pneumonia.
Fig. \(a, b) shows the levels of total antibody of each immunoglobulin class in
healthy children and children with pneumonia, respectively. Total IgG and total
IgA in healthy children show a steady increase with age up to 24 months and levels
were almost the same in children with pneumonia and in healthy children for each
class of immunoglobulin. Total IgM levels failed to show any relationship with
age, but appeared to be higher in sick children under 9 months of age. This
difference, however, may have been a chance effect associated with small sample
numbers since it is not statistically significant.
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Table 1. Distribution
Number of
specimens
1
2
3
4
5
Total
of number
Frequency
20
31
11
7
2
71
of specimens per child
Percentage
of children
28-2
43-7
15-5
9-9
2-8
1-5
l
g
0-5
-0-5
(a)
L,,-\_;±—C"- -"
15
0-5
-0-5
(b)
JL___j__i
<3 3-5 6-8 9-11 12-17 18-23 24+ <3 3-5 6-8 9-11 12-17 18-23 24+
Age (months)
Fig. 1. Log-transformed immunoglobulin concentrations in children, (a) Total
immunoglobulin levels in healthy children. Total IgG+ 1 S.D. ( ); total IgA+ 1 S.D.
( ); total IgM+ 1 S.D. ( ). (6) Total immunoglobulin levels in sick children. Total
IgG+1 S.D. ( ); total IgA+1 S.D. ( ); total IgM+1 S.D. ( ).
Table 2 gives the means and standard deviations of the log-transformed titres
of the IgG and IgA class antibodies directed against the eight pneumococcal
serotypes selected, separately for both healthy and sick children. There is
considerable variation between the serotypes in the mean levels, with standard
deviations which are quite large in relation to the means. Fig. 2 shows the age
dependence of geometric mean titres for the IgG antibodies. In 5 of the 8 serotypes
specific IgG levels in healthy children show a rapid and dramatic decline over the
first year, before rising again. Regression analysis and inspection of the raw data
including exact ages indicated that the minimum levels were generally at
approximately 9-11 months. Serotypes 6 and 23 show quite low levels of specific
IgG in the youngest age group, but also low levels in older age groups, and the
same general trend is evident of a fall at low ages and rise later.
IgG anti-serotype 3 was exceptional in that the lowest titres were in the
specimens from the youngest children. In order to determine whether this was a
chance finding, or whether it reflected an absence of transfer of antibodies to this
serotype across the placenta, we tested 24 placental sera from individuals
unrelated to those in the main sample. As shown in Table 3, only three of the
placental sera had detectable levels of serotype-3-specific IgG. Levels of specific
IgA in the placental sera were minimal for all eight serotypes tested.
Specific IgG antibody titres for children with pneumonia showed the same
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Table 2. Titres of specific anti-PPS antibodies in community study
113
Serotype
IgG 2
3
5
6B
7F
14
19F
23F
IgA 2
3
5
6B
7F
14
19F
23F
AT*
94
78
94
80
80
83
92
95
96
89
78
87
82
70
94
89
Healthy
GMTt
144-8
96-7
309-4
27-1
164-4
1131
286-5
46-8
39-7
29-3
14-4
231
18-8
25-2
38-9
23-7
children
L
°ge
r
Mean
4-98
4-57
5-73
3-30
510
4-73
5-66
3-85
3-68
3-38
2-67
314
2-93
3-23
3-66
316
titre
' ^
S.D.
116
1-52
1-08
1-24
119
1-23
1-39
1-33
116
1-45
0-88
0-68
0-75
0-85
1-20
0-91
Children with
A
N*
55
47
57
49
47
47
54
55
56
49
45
53
46
48
56
53
GMTf
100-8
68-3
224-2
26-3
110-3
1071
203-6
251
39-7
29-2
12-7
20-6
22-2
241
331
30-9
pneumonia
L
°ge
A
Mean
4-61
4-22
5-41
3-27
4-70
4-67
5-32
3-22
3-68
3-37
2-54
302
310
318
3-50
3-43
titre
S.D.
110
1-32
0-97
1-40
1-21
1-42
1-52
1-22
1-22
1-21
106
0-77
0-81
0-85
1-30
0-86
* Numbers of samples tested varied because in some cases the volume of serum was
insufficient to carry out all tests,
t Geometric mean titre.
general trends as for healthy children (Fig. 2). There is a general tendency for the
levels in sick children to be somewhat lower than those in healthy children, but it
is not obvious from the figure whether this might be simply a chance effect. The
likelihood ratio test and examination of parameter estimates showed that the
specific IgG titres were statistically significantly lower among children with
pneumonia (xl = 5-6, P = 0-018) but the magnitude of the differences is much less
than that previously observed between community controls and inpatients by
Witt and colleagues [6, 7]. This is consistent with the milder degree of pneumonia
in the children of the present study than in the hospitalized patients of the earlier
one.
The age dependence of the specific IgA class antibody levels is shown in Fig.
3. Serotypes 2, 3 and 19 show steep increases in antibody level with age, whilst
the other serotypes show only small age trends. There is no clear association with
health status (xl = 0-4, P = 0-53).
In 218/2185 of the specific antibody assays, the serotype of the assay was
cultured from the nasal swab collected at the same time as the blood sample.
Specific IgG and IgA antibody levels in the serum were slightly higher when the
same serotype was carried in the nose (data not shown). However, these differences
were not statistically significant (IgA: x\ = 2-2, P = 013; IgG: #? = M, P = 0-29).
DISCUSSION
This report describes the natural acquisition of anti-pneumococcal antibodies in
children in the highlands of Papua New Guinea. As in many other developing
countries, levels of exposure to respiratory pathogens, especially S. pneumoniae,
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48 0
Age (months)
12 24 36 48
Fig. 2. For legend see opposite.
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Table 3. Mean loge titres of specific anti-PPS IgG in 24 cord blood samples
Serotype
2
3
5
6B
7F
14
19F
23F
Mean of
positives
310
2-79
3-75
2-85
317
3-35
3-63
2-82
S.D.
0-78
0-33
0-61
0-80
100
0-62
0-78
0-52
No. with
detectable
antibody
24
3
24
24
24
24
24
24
are very high [8]. This has important implications for the development of
immunity in young children.
Studies in developed countries have shown that young children respond poorly
to pneumococcal polysaccharide antigens, and the response is serotype dependent
with a general tendency to increase with age. An exception to this trend occurs in
children 18-23 months of age who show significantly lower levels of anti-
pneumococcal antibodies than children 12—17 months [13, 14]. Total serum IgG
levels in these children are high at birth but decline to a minimum level at
3 months before beginning to rise again [15]. Total IgA and IgM levels show
no initial decline, but increase progressively as the child grows older. The decline
in total IgG presumably indicates a decline in maternally derived antibodies as
the immune system of the child begins to mature [15].
In this study, analysis of both total and specific anti-PPS IgA titres did show
an increase with age; however, antibodies of the IgG and IgM classes showed
different patterns of age-dependence from those found in industrialized countries.
Total IgM levels showed no tendency to increase with age, and were highest in
children under 12 months of age who were sick with pneumonia. In contrast to the
situation in developed countries, where the infant is faced with only occasional
infections and the IgM response gradually builds up, the Papua New Guinean
child is faced with a barrage of infections from birth onwards. Much of the total
IgM observed presumably represents the primary immune response to a range of
pathogens, including respiratory pathogens such as S. pneumoniae.
Raised total serum IgG concentrations in PNG highlands children compared to
expatriate controls have been demonstrated elsewhere [6]. Total IgG levels in the
present study showed no initial decline and gradually rose over the first 2 years of
life. The absence of an initial decline may reflect the small sample size in the
youngest age group but the high levels of total IgG would be expected to lead to
rapid turnover and hence to hasten catabolism of maternally derived IgG and the
early onset of the child's own IgG synthesis. The same factors probably contribute
to the rapid initial decline of IgG anti-PPS antibody and the rapid decay observed
on serial correlations in antibody levels. Specific anti-PPS IgG to most serotypes
shows a decline over the first 6—8 months reaching minimal levels at 9—11 months
Fig. 2. Geometric mean titres of serotype-specific IgG by age group and health status.
Age groups are 0- < 6 months, 6- < 12 months, 12- < 24 months and 24 months +.
(a), Serotype 2, (b) serotype 3, (c) serotype 5, (d) serotype 6B, (e) serotype 7F, (/)
serotype 14, (g) serotype 19F, (h) serotype 23F. - Q - , Sick; - # - , healthy.
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but with detectable antibody levels in all age groups. A similar study done in
English children less than 10 years of age shows a decline in IgG anti-PPS levels
in the first 3 months reaching minimum levels at 4-8 months of age, and remaining
low until after 2 years of age [16]. A rapid decline in maternal antibodies has
also been shown to occur with measles antibodies [17] and is likely to occur for
antibody to other encapsulated bacteria such as H. influenzae type b.
There are differences between serotypes in the age-dependence of the response.
IgG antibodies raised against some pneumococcal serotypes do not cross the
placenta. In North American children specific antibodies to serotype 7 showed
reduced transfer across the placenta [18]. In our study, we found that serotype 3
was exceptional both in showing the lowest levels in very young children and in
its absence from most placental sera. Antibodies to serotype 7 were found in all
placental sera tested. Possible explanations for this contrast between Melanesians
and North Americans include differences between the two populations either in
immunoglobulin isotype switching, or in immunoglobulin allotype polymor-
phisms. The immune system does not respond uniformly to all serotypes of
pneumococcus. Serotype 6, for example, does not elicit a good response even when
the children are vaccinated against this serotype [4, 5, 7, 14]. However, in the
present study children who had high levels of IgG anti-PPS antibody for a
particular serotype tended to show a relatively high response to other serotypes
and high IgA for that serotype. This phenomenon may result from high early
exposure to a range of bacteria in the environment. In addition, heterotypic or
non-specific cross-reactivity may be established. S. pneumoniae type 6 is known to
cross-react with H. influenzae type b [19, 20]. Cross-reactions between K30, K42
and K85 antigens of Escherichia coli and antisera to types 6, 25 and 5, respectively,
have been reported by Heidelberger and his colleagues [21]. Similar cross-reaction
has been reported for Mycoplasma pneumoniae [22].
The present analyses do not address directly the question of whether the
antibodies are protective. However, the finding that pneumonia patients had
significantly lower levels of anti-PPS IgG than healthy children of the same age
is consistent with the concept of specific IgG offering protection. The data suggest
that this aggregated effect operated at all ages if not all serotypes (see Fig. 2) but
the number of samples by age was too small for conclusive evidence. Most of
the cases were classed as mild pneumonia, and were not eligible for admission to
hospital. Witt and colleagues [6] found a much larger difference among children
under 6 months between hospitalized children with moderate and severe
pneumonia and healthy controls in anti-PPS IgG levels than was found in this
study. This is consistent with the finding of Lehmann and colleagues [23] that
pneumococcal vaccination was associated with a reduced incidence of moderate
and severe but not mild pneumonia. WTe could not detect any relationship between
morbidity and levels of total IgG, so the effect is associated with specific rather
than non-specific IgG activity.
Our results suggest that a natural immune response to S. pneumoniae develops
in Papua New Guinean children well before their second birthday. However,
Fig. 3. Geometric mean titres of serotype-specific IgA by age group and health status.
Age groups are 0- < 6 months, 6- < 12 months, 12- < 24 months and 24 months +.
(a), Serotype 2, (6) serotype 3, (c) serotype 5, (d) serotype 6B, (e) serotype 7F, (/)
serotype 14, (g) serotype 19F, (h) serotype 23F. -Q-, Sick; - # - , healthy.
of use, available at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268800056739
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 12:54:51, subject to the Cambridge Core terms
118 W. S. POMAT AND OTHERS
maternal antibody is lost early, exposing children under 18 months of age to high
rates of infection. To be effective, vaccination strategies must aim to establish
immunity during this critical period of susceptibility. The success of such
vaccination strategies might be limited by a high rate of catabolism of antibody
resulting from high total antibody levels. We are now using the ELISA system to
examine the antibody response to a 23-valent pneumococcal vaccine (Institut
Merieux) in children from 4 months of age.
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